跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EM-100
首页
药物
EM-100
EM-100
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Method for preparing microbial fermentation preparations of astragalus roots
CN 101664432 A
申请人: TIANJIN SHENGJI GROUP CO LTD
优先权: 2008
CN
Guanidine-benzoin derivative reaction and application of guanidine-benzoin derivative reaction in rapid detection by high performance liquid chromatography
CN 102375034 A
申请人: MINGHONG JIA
优先权: 2010
CN
Traditional Chinese medicine preparation method
CN 103908475 A
申请人: SHENZHEN XINHUA NANFANG BIOTECHNOLOGY CO LTD
优先权: 2014
CN
一种口服液和舌下喷剂及其制备方法
CN 103948928 B
申请人: 曹志远
优先权: 2014
CN
种防治生猪胃肠炎的益生菌发酵中药制剂及其制备工艺
CN 104367871 B
申请人: 福建省希望生物科技有限公司
优先权: 2014
CN
Traditional Chinese medicine veterinary drug for treating pig respiratory disease, preparation method and applications thereof
CN 104984174 A
申请人: HEILONGJIANG ANIMAL DISEASE PREVENTION AND CONTROL CT
优先权: 2015
CN
Medicine for phlegm fire, tuberculosis, crewels and gall
CN 105106370 A
申请人: FOSHAN CITY SHUNDE DISTR BAOTONG METAL TECHNOLOGY CO LTD
优先权: 2015
CN
Medicine used for treating tuberculosis, scrofula and gall induced by phlegm fire
CN 105031432 A
申请人: FOSHAN SHUNDE BAOTONG METAL SCIENCE & TECHNOLOGY CO LTD
优先权: 2015
CN
CN 105031434 A
申请人: FOSHAN SHUNDE BAOTONG METAL SCIENCE & TECHNOLOGY CO LTD
优先权: 2015
CN
CN 105031074 A
申请人: FOSHAN SHUNDE BAOTONG METAL SCIENCE & TECHNOLOGY CO LTD
优先权: 2015
CN
CN 105031435 A
申请人: FOSHAN SHUNDE BAOTONG METAL SCIENCE & TECHNOLOGY CO LTD
优先权: 2015
CN
CN 105031433 A
申请人: FOSHAN SHUNDE BAOTONG METAL SCIENCE & TECHNOLOGY CO LTD
优先权: 2015
CN
Medicine for treating scrofula and thyroid tumor caused by phlegm-fire tuberculosis
CN 105125757 A
申请人: FOSHAN CITY SHUNDE DISTR JINTONG METAL TECHNOLOGY CO LTD
优先权: 2015
CN
Drug for pyrophlegm, tuberculosis, scrofula and galls
CN 105079473 A
申请人: FOSHAN CITY SHUNDE DISTR BAOTONG METAL TECHNOLOGY CO LTD
优先权: 2015
CN
第 1 / 3 页
上一页
下一页
药物
反馈